Fas LIGAND-TRANSFECTED MYOBLASTS AND ISLET CELL TRANSPLANTATION1-Reference-Cited by-同舟云学术

Fas LIGAND-TRANSFECTED MYOBLASTS AND ISLET CELL TRANSPLANTATION1

Published:2000-05 Issue:9 Volume:69 Page:1972-1976
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Turvey Stuart E.,Gonzalez-Nicolini Valeria,Kingsley Cherry I.,Larregina Adriana T.,Morris Peter J.,Castro Maria G.,Lowenstein Pedro R.,Wood Kathryn J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice

2. Transgenic expression of CD95 ligand on islet cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts

3. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

4. Gene transfer of Fas ligand induces tumor regression in vivo

5. Antitumor effect of locally produced CD95 ligand

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The FasLane to ocular pathology—metalloproteinase cleavage of membrane‐bound FasL determines FasL function;Journal of Leukocyte Biology;2021-02-10

2. Approaches to the Induction of Tolerance;Kidney Transplantation - Principles and Practice;2019

3. Cell death‐independent activities of the death receptorsCD95,TRAILR1, andTRAILR2;The FEBS Journal;2016-12-14

4. Life in the Fas lane: differential outcomes of Fas signaling;Cellular and Molecular Life Sciences;2013-04-12

5. Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-Producing Cell Clusters;PLoS ONE;2010-06-04